Table 1.
Study | Diabetes type | AA with PDR, n | Risk factors for PDR reported | Risk factors for PDR reported in AA separately |
---|---|---|---|---|
Davis et al 199819 | T1D, T2D | 176* | Yes | No |
Arfken et al 199821 | T1D | 17 | Yes | No |
Harris et al 19988 | T2D | 5* | No | No |
Roy 200017, 30 | T1D | 137 | Yes | Yes |
Klein et al 200211 | T1D, T2D | 16 | No | No |
Klein et al 20023 | T2D | 2* | No | No |
Emanuele et al 20055 | T2D | <74† | No | No |
Wong et al 200610 | T2D | 26‡ | No | No |
Zhang et al 20109 | T1D, T2D | 28‡ | No | No |
Current study | T2D | 290 | Yes | Yes |
The exact number of patients with PDR was not reported; this approximation is based on percentage of AA patients and PDR participants
74 was the number of AA participants with moderate non-proliferative diabetic retinopathy or worse; this study did not report the exact numbers or percentages of patients with PDR
Number of patients with vision-threatening retinopathy which includes severe non-proliferative diabetic retinopathy, clinically significant macular edema and PDR.
AA, African American; PDR, proliferative diabetic retinopathy; T1D, type 1 diabetes; T2D, type 2 diabetes